E72.04
Cystinosis
Billable FY2026 2025-10-01 → 2026-09-30
Exclusions 15 never code together
E72code
E70-E88block
E00-E89chapter
Excludes1
- transitory endocrine and metabolic disorders specific to newborn (P70-P74)P70-P74
Excludes1 — never code together. The excluded condition and this one are mutually exclusive.
Excludes2 — not included here, but the patient may have both. Code both when documented.
Instructional notes 2
E72.04code
Inclusion terms
- Fanconi (-de Toni) (-Debré) syndrome with cystinosis
E00-E89chapter
Notes
- All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.E05.8E07.0E16-E31E34.-
Index entries leading here 10
- Abderhalden-Kaufmann-Lignac syndrome (cystinosis) E72.04
- Disorder (of) — see also Disease
- Pyelonephritis — see also Nephritis, tubulo-interstitial
- in (due to)
- cystinosis E72.04
- in (due to)
- Cystinosis (malignant) E72.04
- Syndrome — see also Disease
- De Toni-Fanconi (-Debré) syndrome E72.09
- with cystinosis E72.04
- Disease, diseased — see also Syndrome
- Lignac's (cystinosis) E72.04
- Fanconi (-de Toni)(-Debré) syndrome E72.09
- with cystinosis E72.04
- Lignac (-de Toni) (-Fanconi) (-Debré) disease or syndrome E72.09
- with cystinosis E72.04
- Toni-Fanconi syndrome (cystinosis) E72.09
- with cystinosis E72.04
Alongside this code 5 same parent — E72.0
Medications 1
MED-RT files conditions by MeSH, which carves the world differently from ICD-10. These are name matches on this code's description, offered as candidates — not as an assertion that they are this code.
Additional references
AHA Coding Clinic® Licence required
Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.